Suppression of ischemia in arterial occlusive disease by JNK-promoted native collateral artery development

  1. Kasmir Ramo
  2. Koichi Sugamura
  3. Siobhan Craige
  4. John Keaney
  5. Roger J Davis  Is a corresponding author
  1. University of Massachusetts Medical School, United States
  2. UMASS Medical School, United States

Abstract

Arterial occlusive diseases are major causes of morbidity and mortality. Blood flow to the affected tissue must be restored quickly if viability and function are to be preserved. We report that disruption of the mixed-lineage protein kinase (MLK) - cJun NH2-terminal kinase (JNK) signaling pathway in endothelial cells causes severe blockade of blood flow and failure to recover in the murine femoral artery ligation model of hindlimb ischemia. We show that the MLK-JNK pathway is required for the formation of native collateral arteries that can restore circulation following arterial occlusion. Disruption of the MLK-JNK pathway causes decreased Dll4/Notch signaling, excessive sprouting angiogenesis, and defects in developmental vascular morphogenesis. Our analysis demonstrates that the MLK-JNK signaling pathway is a key regulatory mechanism that protects against ischemia in arterial occlusive disease.

Data availability

The following data sets were generated

Article and author information

Author details

  1. Kasmir Ramo

    Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, United States
    Competing interests
    No competing interests declared.
  2. Koichi Sugamura

    Cardiovascular Medicine Division, University of Massachusetts Medical School, Worcester, United States
    Competing interests
    No competing interests declared.
  3. Siobhan Craige

    Cardiovascular Medicine Division, University of Massachusetts Medical School, Worcester, United States
    Competing interests
    No competing interests declared.
  4. John Keaney

    Department of Medicine, UMASS Medical School, Worcester, United States
    Competing interests
    No competing interests declared.
  5. Roger J Davis

    Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, United States
    For correspondence
    roger.davis@umassmed.edu
    Competing interests
    Roger J Davis, Reviewing editor, eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0130-1652

Funding

National Institute of Diabetes and Digestive and Kidney Diseases (R01DK107220)

  • Roger J Davis

National Heart, Lung, and Blood Institute (R01HL09122)

  • John Keaney

Howard Hughes Medical Institute (Investigatorship)

  • Roger J Davis

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Fiona M Watt, King's College London, United Kingdom

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (#A1032) of the University of Massachusetts Medical School, Tufts University School of Medicine, and Brigham & Women's Hospital.

Version history

  1. Received: June 2, 2016
  2. Accepted: August 8, 2016
  3. Accepted Manuscript published: August 9, 2016 (version 1)
  4. Version of Record published: August 25, 2016 (version 2)

Copyright

© 2016, Ramo et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,038
    views
  • 447
    downloads
  • 13
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Kasmir Ramo
  2. Koichi Sugamura
  3. Siobhan Craige
  4. John Keaney
  5. Roger J Davis
(2016)
Suppression of ischemia in arterial occlusive disease by JNK-promoted native collateral artery development
eLife 5:e18414.
https://doi.org/10.7554/eLife.18414

Share this article

https://doi.org/10.7554/eLife.18414

Further reading

    1. Cell Biology
    2. Stem Cells and Regenerative Medicine
    Rajdeep Banerjee, Thomas J Meyer ... David D Roberts
    Research Article

    Extramedullary erythropoiesis is not expected in healthy adult mice, but erythropoietic gene expression was elevated in lineage-depleted spleen cells from Cd47−/− mice. Expression of several genes associated with early stages of erythropoiesis was elevated in mice lacking CD47 or its signaling ligand thrombospondin-1, consistent with previous evidence that this signaling pathway inhibits expression of multipotent stem cell transcription factors in spleen. In contrast, cells expressing markers of committed erythroid progenitors were more abundant in Cd47−/− spleens but significantly depleted in Thbs1−/− spleens. Single-cell transcriptome and flow cytometry analyses indicated that loss of CD47 is associated with accumulation and increased proliferation in spleen of Ter119CD34+ progenitors and Ter119+CD34 committed erythroid progenitors with elevated mRNA expression of Kit, Ermap, and Tfrc. Induction of committed erythroid precursors is consistent with the known function of CD47 to limit the phagocytic removal of aged erythrocytes. Conversely, loss of thrombospondin-1 delays the turnover of aged red blood cells, which may account for the suppression of committed erythroid precursors in Thbs1−/− spleens relative to basal levels in wild-type mice. In addition to defining a role for CD47 to limit extramedullary erythropoiesis, these studies reveal a thrombospondin-1-dependent basal level of extramedullary erythropoiesis in adult mouse spleen.

    1. Cell Biology
    Makiko Kashio, Sandra Derouiche ... Makoto Tominaga
    Research Article

    Reports indicate that an interaction between TRPV4 and anoctamin 1 (ANO1) could be widely involved in water efflux of exocrine glands, suggesting that the interaction could play a role in perspiration. In secretory cells of sweat glands present in mouse foot pads, TRPV4 clearly colocalized with cytokeratin 8, ANO1, and aquaporin-5 (AQP5). Mouse sweat glands showed TRPV4-dependent cytosolic Ca2+ increases that were inhibited by menthol. Acetylcholine-stimulated sweating in foot pads was temperature-dependent in wild-type, but not in TRPV4-deficient mice and was inhibited by menthol both in wild-type and TRPM8KO mice. The basal sweating without acetylcholine stimulation was inhibited by an ANO1 inhibitor. Sweating could be important for maintaining friction forces in mouse foot pads, and this possibility is supported by the finding that wild-type mice climbed up a slippery slope more easily than TRPV4-deficient mice. Furthermore, TRPV4 expression was significantly higher in controls and normohidrotic skin from patients with acquired idiopathic generalized anhidrosis (AIGA) compared to anhidrotic skin from patients with AIGA. Collectively, TRPV4 is likely involved in temperature-dependent perspiration via interactions with ANO1, and TRPV4 itself or the TRPV4/ANO 1 complex would be targeted to develop agents that regulate perspiration.